CLCNKA Gene Bartter Syndrome Type 4b Genetic Test
Components:
- Test Name: CLCNKA Gene Bartter syndrome type 4b Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for CLCNKA Gene Bartter syndrome type 4b NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CLCNKA Gene Bartter syndrome type 4b NGS Genetic DNA Test gene CLCNKA.
Test Details:
The CLCNKA gene is associated with Bartter syndrome type 4b, a rare genetic disorder that affects the kidneys. This syndrome is characterized by an imbalance of electrolytes in the body, leading to symptoms such as excessive urination, dehydration, and abnormal growth.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. In the context of Bartter syndrome type 4b, NGS genetic testing can identify mutations or variations in the CLCNKA gene that may be responsible for the disorder.
By performing this test, healthcare professionals can confirm a diagnosis of Bartter syndrome type 4b and provide appropriate treatment and management strategies for affected individuals. Additionally, genetic testing can also help in identifying carriers of the gene mutation within families and enable informed family planning decisions.
It is important to consult with a healthcare provider or genetic counselor to understand the implications of genetic testing and to determine if it is appropriate in your specific case.
| Test Name | CLCNKA Gene Bartter syndrome type 4b Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Hepatology Nephrology Endocrinology Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CLCNKA Gene Bartter syndrome type 4b NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CLCNKA Gene Bartter syndrome type 4b NGS Genetic DNA Test gene CLCNKA |
| Test Details |
The CLCNKA gene is associated with Bartter syndrome type 4b, a rare genetic disorder that affects the kidneys. This syndrome is characterized by an imbalance of electrolytes in the body, leading to symptoms such as excessive urination, dehydration, and abnormal growth. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, providing a comprehensive evaluation of an individual’s genetic makeup. In the context of Bartter syndrome type 4b, NGS genetic testing can identify mutations or variations in the CLCNKA gene that may be responsible for the disorder. By performing this test, healthcare professionals can confirm a diagnosis of Bartter syndrome type 4b and provide appropriate treatment and management strategies for affected individuals. Additionally, genetic testing can also help in identifying carriers of the gene mutation within families and enable informed family planning decisions. It is important to consult with a healthcare provider or genetic counselor to understand the implications of genetic testing and to determine if it is appropriate in your specific case. |
